Global Venous Thromboembolism Therapeutics Market Size, Status and Forecast 2022
- QYR2284308
- 101 Pages
- December 2017
- Medical Devices
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb (BMS)
Bayer HealthCare
Pfizer
Leo Pharma
Portola Pharmaceuticals
ThromboGenics
Ionis Pharmaceuticals
GlycoMimetics
BioInvent International
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, the product can be split into
Factor Xa Inhibitors
Direct Thrombin Inhibitors
Heparin
Vitamin K Antagonists
Other
Market segment by Application, Venous Thromboembolism Therapeutics can be split into
Hospital Pharmacies
Retail Pharmacies
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Venous Thromboembolism Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Venous Thromboembolism Therapeutics
1.1 Venous Thromboembolism Therapeutics Market Overview
1.1.1 Venous Thromboembolism Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Venous Thromboembolism Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Venous Thromboembolism Therapeutics Market by Type
1.3.1 Factor Xa Inhibitors
1.3.2 Direct Thrombin Inhibitors
1.3.3 Heparin
1.3.4 Vitamin K Antagonists
1.3.5 Other
1.4 Venous Thromboembolism Therapeutics Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Other
2 Global Venous Thromboembolism Therapeutics Competition Analysis by Players
2.1 Venous Thromboembolism Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Johnson & Johnson
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Sanofi
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Daiichi Sankyo
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bristol-Myers Squibb (BMS)
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bayer HealthCare
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Pfizer
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Leo Pharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Portola Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 ThromboGenics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Venous Thromboembolism Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Ionis Pharmaceuticals
3.12 GlycoMimetics
3.13 BioInvent International
4 Global Venous Thromboembolism Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Venous Thromboembolism Therapeutics Market Size by Type (2012-2017)
4.2 Global Venous Thromboembolism Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Venous Thromboembolism Therapeutics in Future
4.4 Top Consumer/End Users of Venous Thromboembolism Therapeutics
5 United States Venous Thromboembolism Therapeutics Development Status and Outlook
5.1 United States Venous Thromboembolism Therapeutics Market Size (2012-2017)
5.2 United States Venous Thromboembolism Therapeutics Market Size and Market Share by Players (2016 and 2017)
6 EU Venous Thromboembolism Therapeutics Development Status and Outlook
6.1 EU Venous Thromboembolism Therapeutics Market Size (2012-2017)
6.2 EU Venous Thromboembolism Therapeutics Market Size and Market Share by Players (2016 and 2017)
7 Japan Venous Thromboembolism Therapeutics Development Status and Outlook
7.1 Japan Venous Thromboembolism Therapeutics Market Size (2012-2017)
7.2 Japan Venous Thromboembolism Therapeutics Market Size and Market Share by Players (2016 and 2017)
8 China Venous Thromboembolism Therapeutics Development Status and Outlook
8.1 China Venous Thromboembolism Therapeutics Market Size (2012-2017)
8.2 China Venous Thromboembolism Therapeutics Market Size and Market Share by Players (2016 and 2017)
9 India Venous Thromboembolism Therapeutics Development Status and Outlook
9.1 India Venous Thromboembolism Therapeutics Market Size (2012-2017)
9.2 India Venous Thromboembolism Therapeutics Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Venous Thromboembolism Therapeutics Development Status and Outlook
10.1 Southeast Asia Venous Thromboembolism Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Venous Thromboembolism Therapeutics Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Venous Thromboembolism Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Venous Thromboembolism Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Venous Thromboembolism Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Venous Thromboembolism Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Venous Thromboembolism Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Venous Thromboembolism Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Venous Thromboembolism Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Venous Thromboembolism Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
12 Venous Thromboembolism Therapeutics Market Dynamics
12.1 Venous Thromboembolism Therapeutics Market Opportunities
12.2 Venous Thromboembolism Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Venous Thromboembolism Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Venous Thromboembolism Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Venous Thromboembolism Therapeutics Product Scope
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) (2012-2017)
Table Global Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Venous Thromboembolism Therapeutics Market Share by Regions in 2016
Figure United States Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Venous Thromboembolism Therapeutics Market Share by Type in 2016
Figure Factor Xa Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Direct Thrombin Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Heparin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Vitamin K Antagonists Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Venous Thromboembolism Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Other
Figure Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Venous Thromboembolism Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Venous Thromboembolism Therapeutics Market Size Share by Players in 2016
Figure Venous Thromboembolism Therapeutics Market Size Share by Players in 2017
Table Johnson & Johnson Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Bristol-Myers Squibb (BMS) Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb (BMS) (2012-2017)
Figure Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Bayer HealthCare Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Bayer HealthCare (2012-2017)
Figure Bayer HealthCare Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Leo Pharma Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Leo Pharma (2012-2017)
Figure Leo Pharma Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Portola Pharmaceuticals Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Portola Pharmaceuticals (2012-2017)
Figure Portola Pharmaceuticals Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table ThromboGenics Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of ThromboGenics (2012-2017)
Figure ThromboGenics Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Ionis Pharmaceuticals Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of Ionis Pharmaceuticals (2012-2017)
Figure Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table GlycoMimetics Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of GlycoMimetics (2012-2017)
Figure GlycoMimetics Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table BioInvent International Basic Information List
Table Venous Thromboembolism Therapeutics Business Revenue (Million USD) of BioInvent International (2012-2017)
Figure BioInvent International Venous Thromboembolism Therapeutics Business Revenue Market Share in 2016
Table Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2012
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2013
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2014
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2015
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2016
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2017
Table Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Venous Thromboembolism Therapeutics
Figure United States Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Venous Thromboembolism Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Venous Thromboembolism Therapeutics Market Size Share by Players in 2016
Figure United States Venous Thromboembolism Therapeutics Market Size Share by Players in 2017
Figure EU Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Venous Thromboembolism Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Venous Thromboembolism Therapeutics Market Size Share by Players in 2016
Figure EU Venous Thromboembolism Therapeutics Market Size Share by Players in 2017
Figure Japan Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Venous Thromboembolism Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Venous Thromboembolism Therapeutics Market Size Share by Players in 2016
Figure Japan Venous Thromboembolism Therapeutics Market Size Share by Players in 2017
Figure China Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Venous Thromboembolism Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Venous Thromboembolism Therapeutics Market Size Share by Players in 2016
Figure China Venous Thromboembolism Therapeutics Market Size Share by Players in 2017
Figure India Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Venous Thromboembolism Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Venous Thromboembolism Therapeutics Market Size Share by Players in 2016
Figure India Venous Thromboembolism Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Venous Thromboembolism Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Venous Thromboembolism Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Venous Thromboembolism Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Venous Thromboembolism Therapeutics Market Size Share by Players in 2017
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Regions in 2017
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Regions in 2022
Figure United States Venous Thromboembolism Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Venous Thromboembolism Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Venous Thromboembolism Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Venous Thromboembolism Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Venous Thromboembolism Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Venous Thromboembolism Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2017
Figure Global Venous Thromboembolism Therapeutics Market Size Share by Type in 2022
Table Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Venous Thromboembolism Therapeutics Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
